Supplemental Annuity Collective Trust (SACT) of New Jersey’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Sell
3,693
-236
-6% -$19.8K 0.09% 224
2026
Q1
$315K Buy
3,929
+1,229
+46% +$101K 0.09% 219
2025
Q4
$230K Sell
2,700
-1,800
-40% -$148K 0.06% 203
2025
Q3
$350K Hold
4,500
0.09% 183
2025
Q2
$352K Hold
4,500
0.1% 173
2025
Q1
$326K Hold
4,500
0.1% 179
2024
Q4
$333K Hold
4,500
0.1% 185
2024
Q3
$297K Hold
4,500
0.09% 192
2024
Q2
$416K Hold
4,500
0.13% 164
2024
Q1
$430K Hold
4,500
0.13% 169
2023
Q4
$343K Hold
4,500
0.12% 178
2023
Q3
$312K Hold
4,500
0.12% 178
2023
Q2
$424K Hold
4,500
0.15% 153
2023
Q1
$372K Hold
4,500
0.15% 163
2022
Q4
$336K Hold
4,500
0.14% 176
2022
Q3
$372K Hold
4,500
0.16% 157
2022
Q2
$428K Hold
4,500
0.17% 159
2022
Q1
$530K Hold
4,500
0.17% 154
2021
Q4
$583K Hold
4,500
0.18% 151
2021
Q3
$509K Hold
4,500
0.17% 160
2021
Q2
$466K Hold
4,500
0.15% 170
2021
Q1
$376K Hold
4,500
0.13% 185
2020
Q4
$411K Hold
4,500
0.15% 171
2020
Q3
$359K Hold
4,500
0.15% 166
2020
Q2
$311K Buy
+4,500
New +$320K 0.14% 174
2020
Q1
Sell
-2,700
Closed -$210K 215
2019
Q4
$210K Buy
+2,700
New +$211K 0.09% 218

Other funds holding EW

Supplemental Annuity Collective Trust (SACT) of New Jersey's EW Position: Q2 2026 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey reduced its Edwards Lifesciences (EW) stake by 6% in Q2 2026, selling an estimated $19.8K and leaving 3,693 shares worth $334K. The position accounts for 0.09% of the portfolio, ranked #224.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in EW in Q4 2019 and has held it in 26 quarters since. The position peaked at $583K in Q4 2021. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Supplemental Annuity Collective Trust (SACT) of New Jersey held 3,693 shares of Edwards Lifesciences worth $334K as of Q2 2026.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey sold 236 Edwards Lifesciences shares in Q2 2026, an estimated $19.8K.
  • Edwards Lifesciences made up 0.09% of Supplemental Annuity Collective Trust (SACT) of New Jersey's portfolio in Q2 2026, its #224 holding.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 26 quarters since.
  • Supplemental Annuity Collective Trust (SACT) of New Jersey's Edwards Lifesciences position peaked at $583K in Q4 2021.
  • 973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q2 2026, filed 27 Jul 2026.